| Closed |
SWOG-7916 |
Phase II Evaluation of Gallium Nitrate in Metastatic Urological Malignancies: Testicular, Bladder, Prostate and Kidney |
7/20/1979 |
1/19/1984 |
|
|
Published
|
| Closed |
SWOG-8304 |
Phase II Evaluation of L-Alanosine in Metastatic Carcinoma of the Breast |
5/27/1983 |
5/4/1984 |
|
|
Published
|
| Closed |
SWOG-8519 |
Phase II Evaluation of Methyl-Glyoxal Bis- Guanylhydrazone (MGBG) in Patients With Advanced Bladder Cancer |
1/1/1986 |
5/15/1989 |
|
|
Published
|
| Closed |
S0805 |
Phase II HyperCVAD + Dasatinib with or without Allo SCT for Ph+ ALL |
9/1/2009 |
|
100% |
|
Published
|
| Closed |
S0115 |
Phase II Melphalan + Auto PBSC Trans. for High Risk MM / Amyloidosis - BMT Study |
1/1/2004 |
10/15/2010 |
95% |
|
Published
|
| Closed |
S1108 |
Phase II MLN8237 in Peripheral T-Cell NHL |
10/28/2011 |
6/6/2013 |
100% |
|
Published
|
| Closed |
S0703 |
Phase II Older Previously Untreated Non-M3 AML |
12/1/2008 |
|
93% |
|
Published
|
| Closed |
S0432 |
Phase II Previously Untreated AML in Patients of Age 70 or Older |
9/15/2004 |
2/21/2006 |
100% |
|
Published
|
| Closed |
S0301 |
Phase II Previously Untreated Non-M3 AML in Patients of Age 56 or Older |
10/1/2003 |
12/15/2006 |
100% |
|
Published
|
| Closed |
S0722 |
Phase II RAD001 in MPM |
12/1/2008 |
9/15/2011 |
100% |
|
Published
|
| Closed |
S0530 |
Phase II Relapsed or Refractory ALL |
10/1/2006 |
8/1/2008 |
100% |
|
Published
|
| Closed |
S0434 |
Phase II Relapsing/Resistant Myeloma Previously Treated with Bortezomib |
3/15/2006 |
|
58% |
|
Published
|
| Closed |
S0605 |
Phase II Revlimid Untreated Non-M3, 5q- AML and >= Age 60 |
6/15/2006 |
7/1/2010 |
91% |
|
Published
|
| Closed |
S0933 |
Phase II RO4929097 in Adv Melanoma |
10/28/2010 |
11/15/2011 |
45% |
|
Published
|
| Closed |
S0816 |
Phase II Stage III-IV Hodgkin's: FDG-PET Imaging Study |
7/1/2009 |
12/1/2012 |
100% |
|
Published
|
| Closed |
SWOG-9030 |
Phase II Study of High Dose ARA-C/Mitoxantrone for the Treatment of Relapsed/Refractory Acute Lymphocytic Leukemia |
11/1/1991 |
5/15/1994 |
60% |
|
Published
|
| Closed |
SWOG-8993 |
Phase II Study of High Dose Melphalan with Hemopoietic Stem Cell Support and GM-CSF in Refractory Multiple Myeloma (MM) |
4/15/1991 |
5/1/1996 |
100% |
|
Published
|
| Closed |
SWOG-8517 |
Phase II Study of Platinum and Mitoxantrone in the Treatment of Metastatic Adenocarcinoma of the Prostate |
2/10/1986 |
8/1/1987 |
|
|
Published
|
| Closed |
SWOG-8630 |
Phase II Study of Recombinant DNA Gamma Interferon in Advanced Colorectal Cancer |
5/15/1987 |
11/15/1988 |
|
|
Published
|
| Closed |
SWOG-8742 |
Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Metastatic Sarcoma |
8/1/1988 |
12/1/1989 |
|
|
Published
|
